106 related articles for article (PubMed ID: 18210327)
1. Are gonadotropin-releasing hormone analogs safe and effective for protection of ovarian reserve against chemotherapeutic insult?
Sönmezer M; Taşçi T; Gözüküçük M
Gynecol Endocrinol; 2008 Feb; 24(2):64-5; author reply 66. PubMed ID: 18210327
[No Abstract] [Full Text] [Related]
2. Do GnRH analogs protect against ovarian toxicity of chemotherapy?
Moore HC
Breast Cancer Res Treat; 2009 Oct; 117(3):569-70. PubMed ID: 19234783
[No Abstract] [Full Text] [Related]
3. Chemotherapy-induced female infertility and protective action of gonadotropin-releasing hormone analogues.
Imai A; Furui T
J Obstet Gynaecol; 2007 Jan; 27(1):20-4. PubMed ID: 17365452
[TBL] [Abstract][Full Text] [Related]
4. Absence of conclusive evidence for the safety and efficacy of gonadotropin-releasing hormone analogue treatment in protecting against chemotherapy-induced gonadal injury.
Oktay K; Sönmezer M; Oktem O; Fox K; Emons G; Bang H
Oncologist; 2007 Sep; 12(9):1055-66. PubMed ID: 17914075
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of a gonadotropin-releasing hormone analogue on chemotherapeutic agent-induced ovarian gonadotoxicity: a mouse model.
Tan SJ; Yeh YC; Shang WJ; Wu GJ; Liu JY; Chen CH
Eur J Obstet Gynecol Reprod Biol; 2010 Apr; 149(2):182-5. PubMed ID: 20074846
[TBL] [Abstract][Full Text] [Related]
6. Should gonadotropin releasing hormone analogue be administered to prevent premature ovarian failure in young women with systemic lupus erythematosus on cyclophosphamide therapy?
Sinha R; Dionne JM
Arch Dis Child; 2008 May; 93(5):444-5. PubMed ID: 17908713
[No Abstract] [Full Text] [Related]
7. Preservation of fertility in patients with cancer.
Blumenfeld Z
N Engl J Med; 2009 Jun; 360(25):2680-1; author reply 2682-3. PubMed ID: 19537322
[No Abstract] [Full Text] [Related]
8. Commentary: Ovarian function does not equal fertility does not equal babies.
Moore HC; Theriault RL
Oncologist; 2007 Sep; 12(9):1067-9. PubMed ID: 17914076
[No Abstract] [Full Text] [Related]
9. [Role of gonadotropin releasing hormone analogues for ovarian protection in systemic lupus erythematosus patients treated with cyclophosphamide].
Liang LQ; Qiu Q; Yang XY; Xu HS; Ye YJ; Zhan ZP; Lian F; Chen DY
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(15):1009-11. PubMed ID: 18754430
[TBL] [Abstract][Full Text] [Related]
10. Use of gonadotropin-releasing hormone agonists in patients with Hodgkin's disease for preservation of ovarian function and reduction of gonadotoxicity related to chemotherapy.
Castelo-Branco C; Nomdedeu B; Camus A; Mercadal S; Martínez de Osaba MJ; Balasch J
Fertil Steril; 2007 Mar; 87(3):702-5. PubMed ID: 17173900
[TBL] [Abstract][Full Text] [Related]
11. GnRH analogue for chemotherapy-induced ovarian damage: too early to say?
Peccatori F; Demeestere I
Fertil Steril; 2009 Aug; 92(2):e33; author reply e34. PubMed ID: 19646600
[No Abstract] [Full Text] [Related]
12. Prevention of gonadal toxicity and preservation of gonadal function and fertility in young women with systemic lupus erythematosus treated by cyclophosphamide: the PREGO-Study.
Manger K; Wildt L; Kalden JR; Manger B
Autoimmun Rev; 2006 Apr; 5(4):269-72. PubMed ID: 16697968
[TBL] [Abstract][Full Text] [Related]
13. GnRH-analogues and oral contraceptives for fertility preservation in women during chemotherapy.
Blumenfeld Z; von Wolff M
Hum Reprod Update; 2008; 14(6):543-52. PubMed ID: 18824495
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy-induced gonadotoxicity.
Wang PH; Chao HT; Chao KC
Taiwan J Obstet Gynecol; 2010 Mar; 49(1):1-2. PubMed ID: 20466285
[No Abstract] [Full Text] [Related]
15. Can ovarian suppression with gonadotropin-releasing hormone analogs (GnRHa) preserve fertility in cancer patients?
Rodriguez-Wallberg K; Turan V; Munster P; Oktay K
Ann Oncol; 2016 Feb; 27(2):357. PubMed ID: 26609009
[TBL] [Abstract][Full Text] [Related]
16. Management quandary. Case 2005: Ovarian suppression with chemotherapy in adolescents.
Blumenfeld Z
J Pediatr Adolesc Gynecol; 2004 Dec; 17(6):413-6. PubMed ID: 15603987
[No Abstract] [Full Text] [Related]
17. [Gonadotropin-releasing hormone (GnRH) and its analogs in current medicine].
Karck U; Neulen J; Wieacker P; Breckwoldt M
Med Klin (Munich); 1992 Feb; 87(2):87-93. PubMed ID: 1542289
[No Abstract] [Full Text] [Related]
18. Effect of the gonadotropin-releasing hormone antagonist cetrorelix on the prevention of chemotherapy-induced ovarian damage in women with hematological malignancy.
Digeni A; Symeonidis A; Georgopoulos NA
Int J Gynaecol Obstet; 2012 Jul; 118(1):73-4. PubMed ID: 22503495
[No Abstract] [Full Text] [Related]
19. [Premature ovarian failure: which protocols?].
Merviel P; Lourdel E; Boulard V; Cabry R; Claeys C; Oliéric MF; Sanguinet P; Brasseur F; Henri I; Copin H
Gynecol Obstet Fertil; 2008 Sep; 36(9):872-81. PubMed ID: 18703373
[TBL] [Abstract][Full Text] [Related]
20. Consensus statement on the use of gonadotropin-releasing hormone analogs in children.
Carel JC; Eugster EA; Rogol A; Ghizzoni L; Palmert MR; ; Antoniazzi F; Berenbaum S; Bourguignon JP; Chrousos GP; Coste J; Deal S; de Vries L; Foster C; Heger S; Holland J; Jahnukainen K; Juul A; Kaplowitz P; Lahlou N; Lee MM; Lee P; Merke DP; Neely EK; Oostdijk W; Phillip M; Rosenfield RL; Shulman D; Styne D; Tauber M; Wit JM
Pediatrics; 2009 Apr; 123(4):e752-62. PubMed ID: 19332438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
